BNP Paribas Financial Markets’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACIU
BNP Paribas Financial Markets's ACIU Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its AC Immune (ACIU) stake by 12% in Q2 2026, buying an estimated $796 and bringing the position to 2,699 shares worth $6.42K. The position accounts for ﹤0.01% of the portfolio, ranked #5432.
BNP Paribas Financial Markets first reported a position in ACIU in Q3 2021 and has held it in 15 quarters since. The position peaked at $91.5K in Q3 2021. 34 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.
- BNP Paribas Financial Markets held 2,699 shares of AC Immune worth $6.42K as of Q2 2026.
- BNP Paribas Financial Markets bought 289 AC Immune shares in Q2 2026, an estimated $796.
- AC Immune made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5432 holding.
- BNP Paribas Financial Markets first reported a position in AC Immune in Q3 2021 and has held it in 15 quarters since.
- BNP Paribas Financial Markets's AC Immune position peaked at $91.5K in Q3 2021.
- 34 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.